ArticleNature communications2021
Experimental observation of topological Z
Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Dynamic topological exciton-polaritons enabling ultrafast logic operations.Science advances · 2026Article
- Topological Jackiw-Rebbi states in photonic Van der Waals heterostructures.Light, science & applications · 2026Article
- Towards Floquet Chern insulators of light.Nature nanotechnology · 2025Article
- Polaritonic quantum matter.Nanophotonics (Berlin, Germany) · 2025Review
- Perovskite topological exciton-polariton disclination laser at room temperature.Nature communications · 2025Article
- 2D material exciton-polariton transport on 2D photonic crystals.Science advances · 2025Article
- Chiral flat-band optical cavity with atomically thin mirrors.Science advances · 2024Article
- Observation of perovskite topological valley exciton-polaritons at room temperature.Nature communications · 2024Article
- Realization of ZACS nano · 2024Article
- Strong light-matter coupling in van der Waals materials.Light, science & applications · 2024Review
- Dirac exciton-polariton condensates in photonic crystal gratings.Nanophotonics (Berlin, Germany) · 2024Article
- Polaritonic states trapped by topological defects.Nature communications · 2024Article
- Topological photonics: robustness and beyond.Nature communications · 2024Article
- Effect of O-doping on electronic and optical properties of monolayer MoSeJournal of molecular modeling · 2024Article
- Recent progress of exciton transport in two-dimensional semiconductors.Nano convergence · 2023Review
- Molecular and solid-state topological polaritons induced by population imbalance.Nanophotonics (Berlin, Germany) · 2023Article
- In-plane hyperbolic polariton tuners in terahertz and long-wave infrared regimes.Nature communications · 2023Article
- Photonic Dirac cavities with spatially varying mass term.Science advances · 2023Article
- Topological Photonics on a Small Scale.Small science · 2021Article
- All-optical nonreciprocity due to valley polarization pumping in transition metal dichalcogenides.Nature communications · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The rise of quantum science and technologies motivates photonics research to seek new platforms with strong light-matter interactions to facilitate quantum behaviors at moderate light intensities. Topological polaritons (TPs) offer an ideal platform in this context, with unique properties stemming from resilient topological states of light strongly coupled with matter. Here we explore polaritonic metasurfaces based on 2D transition metal dichalcogenides (TMDs) as a promising platform for topological polaritonics. We show that the strong coupling between topological photonic modes of the metasurface and excitons in TMDs yields a topological polaritonic Z
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.